Galectin Therapeutics (GALT) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.62% |
| Dec 31, 2025 | -74.29% |
| Sep 30, 2025 | 47.06% |
| Jun 30, 2025 | 14.02% |
| Mar 31, 2025 | 39.77% |
| Dec 31, 2024 | -49.11% |
| Sep 30, 2024 | -2.75% |
| Jun 30, 2024 | 31.16% |
| Mar 31, 2024 | -155.54% |
| Dec 31, 2023 | 37.97% |
| Sep 30, 2023 | 22.33% |
| Jun 30, 2023 | 8.89% |
| Mar 31, 2023 | -49.10% |
| Dec 31, 2022 | 13.27% |
| Sep 30, 2022 | -12.37% |
| Jun 30, 2022 | 7.63% |
| Mar 31, 2022 | -15.70% |
| Dec 31, 2021 | -39.08% |
| Sep 30, 2021 | 16.38% |
| Jun 30, 2021 | 6.35% |
| Mar 31, 2021 | -17.88% |
| Dec 31, 2020 | 34.07% |
| Sep 30, 2020 | -215.36% |
| Jun 30, 2020 | 40.43% |
| Mar 31, 2020 | -16.28% |
| Dec 31, 2019 | -154.85% |
| Sep 30, 2019 | 36.70% |
| Jun 30, 2019 | 29.05% |
| Mar 31, 2019 | -63.63% |
| Dec 31, 2018 | -27.27% |
| Sep 30, 2018 | 48.78% |
| Jun 30, 2018 | 12.43% |
| Mar 31, 2018 | 9.94% |
| Dec 31, 2017 | -25.01% |
| Sep 30, 2017 | 37.56% |
| Jun 30, 2017 | -29.48% |
| Mar 31, 2017 | 20.60% |
| Dec 31, 2016 | -41.26% |
| Sep 30, 2016 | 25.29% |
| Jun 30, 2016 | -32.09% |
| Mar 31, 2016 | 24.15% |
| Dec 31, 2015 | 9.50% |
| Sep 30, 2015 | -70.20% |
| Jun 30, 2015 | 30.71% |
| Mar 31, 2015 | -38.48% |
| Dec 31, 2014 | 5.15% |
| Sep 30, 2014 | -36.07% |
| Jun 30, 2014 | 33.35% |
| Mar 31, 2014 | -119.87% |
| Dec 31, 2013 | -10.99% |
| Sep 30, 2013 | 23.24% |
| Jun 30, 2013 | 20.26% |
| Mar 31, 2013 | -38.38% |
| Dec 31, 2012 | 15.78% |
| Sep 30, 2012 | 4.81% |
| Jun 30, 2012 | -46.97% |
| Mar 31, 2012 | 3.63% |
| Dec 31, 2011 | -23.26% |
| Sep 30, 2011 | 17.48% |
| Jun 30, 2011 | -10.90% |
| Mar 31, 2011 | -134.48% |
| Dec 31, 2010 | 29.50% |